Eltek Ltd.
(Registrant)
|
|||
By:
|
/s/ Amnon Shemer | ||
Amnon Shemer | |||
Vice President, Finance and
Chief Financial Officer
|
|||
Press Release
|
· |
Revenues of $8.5 million in the first quarter of 2017
|
· |
Gross profit of $485,000
|
· |
Net loss of $814,000
|
· |
Revenues for the first quarter of 2017 were $8.5 million compared with revenues of $9.8 million in the first quarter of 2016 ($8.6 million excluding Kubatronik);
|
· |
Gross profit was $485,000 (5.7% of revenues) compared with gross profit of $938,000 (9.6% of revenues) in the first quarter of 2016 ($734,000 or 8.5% of revenues excluding Kubatronik);
|
· |
Operating loss was $630,000 compared to an operating loss of $293,000 in the first quarter of 2016 ($342,000 excluding Kubatronik);
|
· |
Net loss was $814,000 or $0.08 per fully diluted share, compared to a net loss of $384,000 or $0.04 per fully diluted share in the first quarter of 2016 ($409,000 or $0.04 per fully diluted share excluding Kubatronik);
|
· |
EBITDA was a negative amount of $210,000 (2.5% of revenues) compared to EBITDA of $167,000 (1.7% of revenues) in the first quarter of 2016 ($88,000 (1% of revenues) excluding Kubatronik);
|
· |
Net cash used in operating activities amounted to $775,000 compared to a positive net cash generation of $890,000 in the first quarter of 2016.
|
Three months ended
|
||||||||
March 31,
|
||||||||
2017
|
2016
|
|||||||
Revenues
|
8,467
|
9,800
|
||||||
Costs of revenues
|
(7,983
|
)
|
(8,863
|
)
|
||||
Gross profit
|
485
|
938
|
||||||
Selling, general and administrative expenses
|
(1,095
|
)
|
(1,198
|
)
|
||||
R&D expenses, net
|
(19
|
)
|
(32
|
)
|
||||
Operating profit (loss)
|
(630
|
)
|
(293
|
)
|
||||
Financial expenses, net
|
(177
|
)
|
(61
|
)
|
||||
Profit (loss) before other income, net
|
(807
|
)
|
(354
|
)
|
||||
Other income, net
|
16
|
0
|
||||||
Profit (loss) before income tax expenses
|
(791
|
)
|
(354
|
)
|
||||
Tax expenses
|
(23
|
)
|
(23
|
)
|
||||
Net Profit (loss)
|
(814
|
)
|
(377
|
)
|
||||
Net loss attributable to non controlling interest
|
0
|
7
|
||||||
Net Profit (loss) attributable to Eltek Ltd.
|
(814
|
)
|
(384
|
)
|
||||
Earnings per share
|
||||||||
Basic and diluted net gain (loss) per ordinary share
|
(0.08
|
)
|
(0.04
|
)
|
||||
Weighted average number of ordinary shares
|
||||||||
used to compute basic and diluted net gain (loss) per
|
||||||||
ordinary share (in thousands)
|
10,143
|
10,143
|
March 31,
|
March 31,
|
|||||||
2017
|
2016
|
|||||||
Assets
|
||||||||
Current assets
|
||||||||
Cash and cash equivalents
|
1,029
|
938
|
||||||
Receivables: Trade, net of provision for doubtful accounts
|
7,007
|
7,692
|
||||||
Other
|
160
|
239
|
||||||
Inventories
|
3,992
|
4,481
|
||||||
Prepaid expenses
|
263
|
202
|
||||||
Total current assets
|
12,451
|
13,552
|
||||||
Deferred taxes
|
(12
|
)
|
1,096
|
|||||
Assets held for employees' severance benefits
|
53
|
50
|
||||||
Fixed assets, less accumulated depreciation
|
8,871
|
10,089
|
||||||
Intangible asset
|
341
|
293
|
||||||
Total assets
|
21,704
|
25,080
|
||||||
Liabilities and Shareholder's equity
|
||||||||
Current liabilities
|
||||||||
Short-term credit and current maturities of long-term debts
|
3,918
|
816
|
||||||
Accounts payable: Trade
|
5,785
|
6,294
|
||||||
Other
|
3,853
|
4,721
|
||||||
Total current liabilities
|
13,556
|
11,831
|
||||||
Long-term liabilities
|
||||||||
Long term debt, excluding current maturities
|
1,803
|
2,727
|
||||||
Employee severance benefits
|
151
|
298
|
||||||
Total long-term liabilities
|
1,954
|
3,025
|
||||||
Equity
|
||||||||
Ordinary shares, NIS 0.6 par value authorized 50,000,000 shares, issued and outstanding 10,142,762
|
1,985
|
1,985
|
||||||
Additional paid-in capital
|
17,270
|
17,270
|
||||||
Cumulative foreign currency translation adjustments
|
2,189
|
2,254
|
||||||
Capital reserve
|
695
|
695
|
||||||
Accumulated deficit
|
(15,945
|
)
|
(11,891
|
)
|
||||
Shareholders' equity
|
6,194
|
10,313
|
||||||
Non controlling interest
|
0
|
(89
|
)
|
|||||
Total equity
|
6,194
|
10,224
|
||||||
Total liabilities and shareholders' equity
|
21,704
|
25,080
|
Non-GAAP EBITDA Reconciliations
|
Three months ended
|
|||||||
March 31,
|
||||||||
2017
|
2016
|
|||||||
GAAP net Income (loss)
|
(814
|
)
|
(384
|
)
|
||||
Add back items:
|
||||||||
Financial expenses (income), net
|
177
|
61
|
||||||
Income tax expense
|
23
|
23
|
||||||
Depreciation and amortization
|
404
|
430
|
||||||
Adjusted EBITDA
|
(210
|
)
|
167
|
Three months ended
|
||||||||
March 31,
|
||||||||
2017
|
2016
|
|||||||
Cash flows from operating activities:
|
||||||||
Net Income (loss)
|
(814
|
)
|
(377
|
)
|
||||
Adjustments to reconcile net loss to net
|
||||||||
cash flows provided by operating activities:
|
||||||||
Depreciation and amortization
|
417
|
467
|
||||||
Capital lose on disposal of fixed assets, net
|
(13
|
)
|
||||||
Revaluation of long term loans
|
3
|
1
|
||||||
Decrease (increase) in Deferred Tax
|
12
|
7
|
||||||
418
|
475
|
|||||||
Decrease (increase) in trade receivables
|
(943
|
)
|
590
|
|||||
Decrease (increase) in other receivables and prepaid expenses
|
58
|
35
|
||||||
Decrease (increase) in inventories
|
161
|
126
|
||||||
Increase (decrease) in trade payables
|
529
|
81
|
||||||
Increase (decrease) in other liabilities and accrued expenses
|
(183
|
)
|
(38
|
)
|
||||
Increase (decrease) in employee severance benefits, net
|
(1
|
)
|
(2
|
)
|
||||
(380
|
)
|
792
|
||||||
Net cash provided by operating activities
|
(775
|
)
|
890
|
Three months ended
|
||||||||
December 31,
|
||||||||
2016
|
2015
|
|||||||
Cash flows from investing activities:
|
||||||||
Owners investment
|
||||||||
Purchase of fixed assets
|
(91
|
)
|
(93
|
)
|
||||
Purchase of Intangible asset
|
-
|
(7
|
)
|
|||||
Net cash used in investing activities
|
(91
|
)
|
(100
|
)
|
||||
Cash flows from financing activities:
|
||||||||
Increase (decrease) in short- term credit
|
859
|
(486
|
)
|
|||||
Repayment of long-term loans from bank
|
(199
|
)
|
(155
|
)
|
||||
Proceeds from long-term loans
|
(36
|
)
|
-
|
|||||
Repayment of credit from fixed asset payables
|
(33
|
)
|
(257
|
)
|
||||
Net cash provided by (used in) financing activities
|
591
|
(898
|
)
|
|||||
Effect of translation adjustments
|
346
|
8
|
||||||
Net increase (decrease) in cash and cash equivalents
|
(205
|
)
|
(100
|
)
|
||||
Cash and cash equivalents at beginning of the period
|
1,234
|
1,038
|
||||||
Cash and cash equivalents at period end
|
1,028
|
938
|
Solo
Three months ended
|
||||||||
March 31,
|
||||||||
2017
|
2016
|
|||||||
Unaudited
|
||||||||
Revenues
|
8,467
|
8,593
|
||||||
Costs of revenues
|
(7,983
|
)
|
(7,859
|
)
|
||||
Gross profit
|
485
|
734
|
||||||
Research and development income, net
|
(19
|
)
|
(32
|
)
|
||||
Selling, general and administrative expenses
|
(1,095
|
)
|
(1,044
|
)
|
||||
Operating profit (loss)
|
(630
|
)
|
(342
|
)
|
||||
Financial expenses, net
|
(177
|
)
|
(44
|
)
|
||||
Profit (loss) before other income, net
|
(807
|
)
|
(386
|
)
|
||||
Other income, net
|
16
|
0
|
||||||
Profit (loss) before income tax expenses
|
(791
|
)
|
(386
|
)
|
||||
Income tax (expenses), net
|
(23
|
)
|
(23
|
)
|
||||
Net Profit (loss)
|
(814
|
)
|
(409
|
)
|
||||
Diluted net loss per ordinary share
|
(0.08
|
)
|
(0.04
|
)
|
||||
Weighted average number of ordinary shares
|
||||||||
used to compute diluted net loss per
|
||||||||
ordinary share (in thousands)
|
10,143
|
10,143
|
March 31,
|
||||||||
2017
|
2016
|
|||||||
Unaudited
|
||||||||
Assets
|
||||||||
Current assets
|
||||||||
Cash and cash equivalents
|
1,029
|
872
|
||||||
Receivables: Trade, net of provision for doubtful accounts
|
7,007
|
7,219
|
||||||
Other
|
160
|
1,323
|
||||||
Inventories
|
3,992
|
4,109
|
||||||
Prepaid expenses
|
263
|
218
|
||||||
Total current assets
|
12,451
|
13,741
|
||||||
Deferred taxes
|
(12
|
)
|
1,096
|
|||||
Assets held for employees' severance benefits
|
53
|
50
|
||||||
Fixed assets, less accumulated depreciation
|
8,871
|
9,410
|
||||||
Investment
|
(334
|
)
|
||||||
Investment
|
341
|
293
|
||||||
Total assets
|
21,704
|
24,256
|
Liabilities and Shareholder's equity
|
||||||||
Current liabilities
|
||||||||
Short-term credit and current maturities of long-term debts
|
3,918
|
816
|
||||||
Accounts payable: Trade
|
5,785
|
5,878
|
||||||
Other
|
3,853
|
4,504
|
||||||
Total current liabilities
|
13,556
|
11,198
|
||||||
Long-term liabilities
|
||||||||
Long term debt, excluding current maturities
|
1,803
|
2,498
|
||||||
Employee severance benefits
|
151
|
247
|
||||||
Total long-term liabilities
|
1,954
|
2,745
|
||||||
Equity
|
||||||||
Ordinary shares, NIS 0.6 par value authorized 50,000,000 shares, issued and outstanding 6,610,107 as of December 31, 2011.
|
1,985
|
1,985
|
||||||
Additional paid-in capital
|
17,270
|
17,270
|
||||||
Cumulative foreign currency translation adjustments
|
2,189
|
2,254
|
||||||
Capital reserve
|
695
|
695
|
||||||
Accumulated deficit
|
(15,945
|
)
|
(11,891
|
)
|
||||
Shareholders' equity
|
6,194
|
10,313
|
||||||
Non controlling interest
|
0
|
0
|
||||||
Total equity
|
6,194
|
10,313
|
||||||
Total liabilities and shareholders' equity
|
21,704
|
24,256
|
Non-GAAP EBITDA Reconciliations
|
Three months ended
|
|||||||
March 31,
|
March 31,
|
|||||||
2017
|
2016
|
|||||||
GAAP net Income (loss)
|
(814
|
)
|
(409
|
)
|
||||
Add back items:
|
||||||||
Financial expenses (income), net
|
177
|
44
|
||||||
Income tax expense
|
23
|
23
|
||||||
Depreciation and amortization
|
404
|
430
|
||||||
Adjusted EBITDA
|
(210
|
)
|
88
|